Is Hepatitis C Virus Carcinogenic?

Slides:



Advertisements
Similar presentations
Lecture 14 - The cell cycle and cell death
Advertisements

Cell Cycle Checkpoint.
Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects  Chi Chen, Ah-Ng Tony Kong  Trends in Pharmacological.
Cellular and Molecular Mechanisms of Liver Injury
The Kinase-Independent, Second Life of CDK6 in Transcription
Stuart Jon Spechler, Rhonda F. Souza  Gastroenterology 
Abhishek Chauhan, David H. Adams  Gastroenterology 
Unraveling the Role of PD-1/PD-L Interactions in Persistent Hepatotropic Infections: Potential for Therapeutic Application?  Henry Radziewicz, Holly L.
Vineela Chukkapalli, Glenn Randall  Gastroenterology 
The Chromosomal Instability Pathway in Colon Cancer
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 132, Issue 3, Pages (March 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
HCV NS5A Inhibitors: The Devil Is in the Details
Cellular and Molecular Mechanisms of Liver Injury
Regulation of mesangial cell proliferation
Hedgehog signaling in the liver
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Dan Gordon  Gastroenterology  Volume 114, Issue 4, (April 1998)
Volume 139, Issue 5, Pages (November 2010)
Is HCV Infection a Neurologic Disorder?
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Making Sense of HDAC2 Mutations in Colon Cancer
Stuart Jon Spechler, Rhonda F. Souza  Gastroenterology 
Mechanisms of HBV-related hepatocarcinogenesis
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Volume 134, Issue 5, Pages (May 2008)
Volume 141, Issue 6, Pages (December 2011)
Bhagelu Ram Achyut, Li Yang  Gastroenterology 
Volume 150, Issue 4, Pages (April 2016)
Molecular mechanisms of diabetic renal hypertrophy
Jean-Michel Pawlotsky  Gastroenterology 
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Roles for KRAS in Pancreatic Tumor Development and Progression
Volume 142, Issue 6, Pages e3 (May 2012)
Timothy M. Block, Ju-Tao Guo  Gastroenterology 
Joshua E. Allen, Wafik S. El-Deiry  Gastroenterology 
Connecting Mitochondria and Innate Immunity
Percy A. Knolle, Robert Thimme  Gastroenterology 
HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
Volume 135, Issue 2, Pages (August 2008)
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
MicroRNAs in Liver Disease
Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle
Nuclear Factor-κB in the Liver: Friend or Foe?
CDK Inhibitors: Cell Cycle Regulators and Beyond
Proteins Kinases: Chromatin-Associated Enzymes?
Jonathan D. Licht, Jake Shortt, Ricky Johnstone  Cancer Cell 
DNA Replication and Oncogene-Induced Replicative Stress
Volume 148, Issue 3, Pages (March 2015)
HATs On for Drug Resistance
Blinded by the Light: The Growing Complexity of p53
Volume 132, Issue 3, Pages (March 2007)
mTOR Regulation by JNK: Rescuing the Starving Intestinal Cancer Cell?
The Expanding Cosmos of Nuclear Receptor Coactivators
Long Noncoding RNAs and Hepatocellular Carcinoma
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Life, Death, and Ubiquitin: Taming the Mule
Volume 138, Issue 6, Pages (May 2010)
DNA Damage and Checkpoint Pathways
Controversies in Liver Transplantation for Hepatitis C
Phases of the Cell Cycle
Phases of the Cell Cycle
Genotype–Phenotype Relationships in Hepatocellular Carcinoma: p53 Inactivation Promotes Tumors With Stem Cell Features  Jean–Charles Nault, Jessica Zucman–Rossi 
Tenets of PTEN Tumor Suppression
Gankyrin: An intriguing name for a novel regulator of p53 and RB
PTEN and p53: Who will get the upper hand?
Presentation transcript:

Is Hepatitis C Virus Carcinogenic? Stanley M. Lemon, David R. McGivern  Gastroenterology  Volume 142, Issue 6, Pages 1274-1278 (May 2012) DOI: 10.1053/j.gastro.2012.01.045 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Disruption of the Rb pathway by HCV NS5B. (A) Rb regulates multiple cellular processes, including cell-cycle progression, apoptosis, DNA replication and repair, cellular differentiation, and senescence. Rb binds to and represses E2F/DP transcription factor complexes. During the G1-/S-phase transition, Rb phosphorylation by cyclin-dependent kinases (CDKs) results in dissociation of Rb from E2F/DP complexes. The derepressed E2F/DP complexes are free to initiate transcription of S-phase–specific genes, thus allowing cell-cycle progression. (B) NS5B interacts with Rb in the cytoplasm of HCV-infected cells, and recruits the E3-ubiquitin ligase E6-associated protein (E6AP) to facilitate ubiquitylation of Rb. (C) Ubiquitylation targets Rb for proteasome-mediated degradation. Loss of Rb results in dysregulation of the many processes that Rb controls. For example, the unscheduled activation of E2F/DP-dependent gene expression can compromise cell-cycle checkpoints that guard against chromosomal instability as well as induce p53-dependent apoptosis. Gastroenterology 2012 142, 1274-1278DOI: (10.1053/j.gastro.2012.01.045) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Direct vs indirect mechanisms of carcinogenesis in the HCV-infected liver. Competing scenarios depicting how liver cancer might arise within an infected cell as the direct result of viral protein expression (left) or in uninfected hepatocytes proliferating in response to the apoptotic death of infected cells (right). Direct vs indirect mechanisms of carcinogenesis are not mutually exclusive and are subject to considerable overlap. The risk of cancer arising via either scenario is likely to be enhanced by the presence of cirrhosis, immune-mediated inflammation, and oxidative stress. Gastroenterology 2012 142, 1274-1278DOI: (10.1053/j.gastro.2012.01.045) Copyright © 2012 AGA Institute Terms and Conditions

Gastroenterology 2012 142, 1274-1278DOI: (10. 1053/j. gastro. 2012. 01 Copyright © 2012 AGA Institute Terms and Conditions

Gastroenterology 2012 142, 1274-1278DOI: (10. 1053/j. gastro. 2012. 01 Copyright © 2012 AGA Institute Terms and Conditions